Brain Malignancies Steering Committee Roster
The Brain Malignancies Steering Committee (BMSC) addresses the design, prioritization, and evaluation of concepts for phase 2, 2/3, and 3 clinical trials in adult and pediatric brain cancers. Committee activities help foster collaboration between groups and institutions engaged in conducting trials. The BMSC's membership comprises NCTN group representatives, NCI-funded consortia representatives, community oncologists, Specialized Programs of Research Excellence (SPORE) representatives, biostatisticians, patient advocates, subject matter experts, and NCI staff.
Co-chairs
Anita Mahajan, M.D.
Mayo Clinic
Rochester, MN
Patrick Y. Wen M.D.
Harvard Medical School
Dana-Farber Cancer Institute
Boston, MA
Members
Manmeet Ahluwalia, M.D., FACP
Cleveland Clinic
Cleveland, OH
David F. Arons, J.D.
National Brain Tumor Society
Newton, MA
David M. Ashley, M.B.B.S., Ph.D.
Duke University School of Medicine
Durham, NC
Daniel Barboriak, M.D.
Duke University Medical Center
Durham, NC
Mitchel Berger, M.D.
University of California San Francisco
San Francisco, CA
Priscilla Brastianos, M.D.
Harvard Medical School
Massachusetts General Hospital
Boston, MA
Paul Brown, M.D.
Mayo Clinic
Rochester, MN
Nicholas A. Butowski, M.D.
University of California San Francisco
San Francisco, CA
Ira J. Dunkel, M.D.
Memorial Sloan Kettering Cancer Center
New York, NY
William Jeffery Edenfield, M.D., M.S.
Prisma Health Cancer Institute
Greenville, SC
Maryam Fouladi, M.D.
Cincinnati Children's Hospital Medical Center
Cincinnati, OH
Susan M. Geyer, Ph.D.
Mayo Clinic
Rochester, MN
John W. Glod, M.D.
National Cancer Institute
Bethesda, MD
Stewart Goldman, M.D.
Phoenix Children's Hospital
Phoenix, AZ
Amanda Haddock
Dragon Master Foundation
Kechi, KS
Andrew B. Lassman, M.D.
Columbia University
New York, NY
Sarah Leary, M.D., M.S.
Seattle Children's Hospital
Seattle, WA
Linda M. Liau, M.D., Ph.D.
University of California Los Angeles
Los Angeles, CA
Michael Lim, M.D.
Stanford University School of Medicine
Stanford, CA
Christine Lu-Emerson, M.D.
Maine Medical Center
Scarborough, ME
Tobey MacDonald, M.D.
Emory University School of Medicine
Atlanta, GA
Bhupinder Mann, M.B.B.S
National Cancer Institute
Bethesda, MD
Minesh Mehta, M.D.
Baptist Health South Florida
Miami, FL
Annette Marie Molinaro, M.A., Ph.D.
University of California San Francisco
San Francisco, CA
Arzu Onar-Thomas, Ph.D.
St. Jude Children's Research Hospital
Memphis, TN
Marshall Pitz, M.D., M.H.S., FRCPC
University of Manitoba
Winnipeg, MB, Canada
Jana Portnow, M.D.
City of Hope Comprehensive Cancer Center
Duarte, CA
David Roberge, M.D.
Centre Hospitalier de l'Université de Montréal
Montréal, QC, Canada
Nathan J. Robison, M.D.
Children's Hospital Los Angeles
Los Angeles, CA
Lawrence V. Rubinstein, Ph.D.
National Cancer Institute
Bethesda, MD
David Schiff, M.D.
University of Virginia
Charlottesville, VA
Malcolm Smith, M.D., Ph.D.
National Cancer Institute
Bethesda, MD
Erik P. Sulman, M.D., Ph.D.
New York University Langone Health
New York, NY
Michael A. Vogelbaum, M.D., Ph.D.
Moffitt Cancer Center
Tampa, FL
Katherine Warren, M.D.
Harvard Medical School
Dana-Farber Cancer Institute
Boston, MA
Jing Wu, M.D., Ph.D.
National Cancer Institute
Bethesda, MD
NCI CCCT Program Director
Abdul Tawab Amiri, Ph.D.
atawab@mail.nih.gov